Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinz Reichmann

Showing results (31-40 of 314) with videos related to

Pageof 32
Sort By:
BMC Neurology|September 24, 2011
Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's diseaseMatthias Löhle, Heinz Reichmann
Journal of Neurology|May 12, 2011
Parkinson's disease: a multi-faceted diseaseWolfgang Jost, Heinz Reichmann
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2010
Iron-dependent functions of mitochondria--relation to neurodegenerationGabriele Gille, Heinz Reichmann
Therapeutic Advances in Neurological Disorders|December 25, 2010
Treatment of dysautonomia in extrapyramidal disordersTjalf Ziemssen, Heinz Reichmann
Journal of Parkinson'S Disease|September 26, 2015
Parkinson's Disease and Gastrointestinal Non Motor Symptoms: Diagnostic and Therapeutic Options - A Practise GuideLisa Klingelhoefer, Heinz Reichmann
Journal of Neural Transmission (Vienna, Austria : 1996)|April 7, 2022
Peter Riederer, a translational neurobiochemistToshiharu Nagatsu, Heinz Reichmann
Journal of Neurology|September 1, 2006
The dopaminergic system: an everlasting challenge. EditorialHeinz Reichmann, Wolfgang Jost
Expert Opinion on Pharmacotherapy|April 9, 2009
Treatment strategies for nonmotor manifestations of Parkinson's diseaseHeinz Reichmann, Tjalf Ziemssen
Journal of the Neurological Sciences|September 11, 2009
Cardiovascular autonomic dysfunction in Parkinson's diseaseTjalf Ziemssen, Heinz Reichmann
Expert Review of Neurotherapeutics|February 1, 2012
Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacaponeHeinz Reichmann, Murat Emre
Pageof 32

Showing results (31-40 of 314) with videos related to

Sort By:
Pageof 32
BMC Neurology|September 24, 2011
Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's diseaseMatthias Löhle, Heinz Reichmann
Journal of Neurology|May 12, 2011
Parkinson's disease: a multi-faceted diseaseWolfgang Jost, Heinz Reichmann
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2010
Iron-dependent functions of mitochondria--relation to neurodegenerationGabriele Gille, Heinz Reichmann
Therapeutic Advances in Neurological Disorders|December 25, 2010
Treatment of dysautonomia in extrapyramidal disordersTjalf Ziemssen, Heinz Reichmann
Journal of Parkinson'S Disease|September 26, 2015
Parkinson's Disease and Gastrointestinal Non Motor Symptoms: Diagnostic and Therapeutic Options - A Practise GuideLisa Klingelhoefer, Heinz Reichmann
Journal of Neural Transmission (Vienna, Austria : 1996)|April 7, 2022
Peter Riederer, a translational neurobiochemistToshiharu Nagatsu, Heinz Reichmann
Journal of Neurology|September 1, 2006
The dopaminergic system: an everlasting challenge. EditorialHeinz Reichmann, Wolfgang Jost
Expert Opinion on Pharmacotherapy|April 9, 2009
Treatment strategies for nonmotor manifestations of Parkinson's diseaseHeinz Reichmann, Tjalf Ziemssen
Journal of the Neurological Sciences|September 11, 2009
Cardiovascular autonomic dysfunction in Parkinson's diseaseTjalf Ziemssen, Heinz Reichmann
Expert Review of Neurotherapeutics|February 1, 2012
Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacaponeHeinz Reichmann, Murat Emre
Pageof 32